Epitope mapping of 2E2-D3, a monoclonal antibody directed against human TDP-43

Neuroscience Letters

Volumn 434, Issue 2, 2008, Pages 170-174

  Zhang, Hai Xin ^a   Tanji, Kunikazu ^a   Mori, Fumiaki ^a   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Epitope mapping; Frontotemporal lobar degeneration; Monoclonal antibody; TDP 43

Indexed keywords

BINDING PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2E2 D3; PROTEIN TDP 43; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EPITOPE MAPPING; HUMAN; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIBODIES, MONOCLONAL; DEMENTIA; DNA-BINDING PROTEINS; EPITOPE MAPPING; HUMANS; MICE; MICE, TRANSGENIC; MUTAGENESIS; RATS; SPECIES SPECIFICITY;

EID: 40849101426     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.01.060     Document Type: Article

References (16)

1. Amador-Ortiz C., Lin W.L., Ahmed Z., Personett D., Davies P., Duara R., Graff-Radford N.R., Hutton M.L., and Dickson D.W. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 61 (2007) 435-445
2. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (2006) 602-611
3. Ayala Y.M., Pantano S., D'Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., and Baralle F.E. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 348 (2005) 575-588
4. Buratti E., and Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276 (2001) 36337-36343
5. Geser F., Winton M.J., Kwong L.K., Xu Y., Xie S.X., Igaz L.M., Garruto R.M., Perl D.P., Galasko D., Lee V.M., and Trojanowski J.Q. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 115 (2008) 123-131
6. Hasegawa M., Arai T., Akiyama H., Nonaka T., Mori H., Hashimoto T., Yamazaki M., and Oyanagi K. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130 (2007) 1386-1394
7. Higashi S., Iseki E., Yamamoto R., Minegishi M., Hino H., Fujisawa K., Togo T., Katsuse O., Uchikado H., Furukawa Y., Kosaka K., and Arai H. Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184 (2007) 284-294
8. Mackenzie I.R.A., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., Eisen A., McClusky L., Kretzschmar H.A., Monoranu C.M., Highley J.R., Kirby J., Siddique T., Shaw P.J., Lee V.M., and Trojanowski J.Q. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61 (2007) 427-434
9. Nakashima-Yasuda H., Uryu K., Robinson J., Xie S.X., Hurtig H., Duda J.E., Arnold S.E., Siderowf A., Grossman M., Leverenz J.B., Woltjer R., Lopez O.L., Hamilton R., Tsuang D.W., Galasko D., Masliah E., Kaye J., Clark C.M., Montine T.J., Lee V.M., and Trojanowski J.Q. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 114 (2007) 221-229
10. Neumann M., Kwong L.K., Truax A.C., Vanmassenhove B., Kretzschmar H.A., Van Deerlin V.M., Clark C.M., Grossman M., Miller B.L., Trojanowski J.Q., and Lee V.M. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J. Neuropathol. Exp. Neurol. 66 (2007) 177-183
11. Neumann M., Mackenzie I.R., Cairns N.J., Boyer P.J., Markesbery W.R., Smith C.D., Taylor J.P., Kretzschmar H.A., Kimonis V.E., and Forman M.S. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 66 (2007) 152-157
12. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
13. Ou S.H.I., Wu F., Harrich D., Garcia-Martinez L.F., and Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995) 3584-3596
14. Probst A., Taylor K.I., and Tolnay M. Hippocampal sclerosis dementia: a reappraisal. Acta Neuropathol. 114 (2007) 335-345
15. Tanji K., Tanaka T., Mori F., Kito K., Takahashi H., Wakabayashi K., and Kamitani T. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am. J. Pathol. 169 (2006) 553-565
16. Zhang H., Tan C.F., Mori F., Tanji K., Kakita A., Takahashi H., and Wakabayashi K. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 115 (2008) 115-122